Please login to the form below

Not currently logged in
Email:
Password:

MSD appoints Jessica Fine as UK external affairs director

She joins the UK pharma company from Lexington Health

MSD Merck Sharp Dohme Jessica FineMSD has appointed Jessica Fine as executive director, external affairs for its UK operations.

She will join MSD, which operates as Merck & Co in the US, in April when she will replace Kate Tillett who retires early next year.

Fine will move to the pharma firm from Lexington Communications, on whose senior management team she sat and where she served as head of Lexington Health.

While there she led the health arm of the business and delivered strategic counsel to a range of organisations and providers across the healthcare sector. She was also highly commended in the Publicis Life Brands Resolute Award for Emerging Leader in Healthcare Communications at last year's Communiqué Awards.

Mike Nally, managing director of MSD in the UK, said: “Jessica has a wealth of experience and expertise in healthcare communications and I'm looking forward welcoming Jessica and the leadership qualities that I know she will bring to this role.”

In her new role heading up MSD's external affairs team in the UK, Fine will cover public affairs, policy and therapy area communications, external and internal communications.

17th December 2015

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...

Infographics